TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NAMENDA XR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

NAMENDA XR

ST13

US500000085642435

Class

5

Filing

85642435

Registration

4415656

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

01/16/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

06/04/2012

Registration date

10/08/2013

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/16/2024

Last transaction

01/16/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/03/2013

First use in commerce

06/03/2013

Drawing code

4

Owner type

99

Owner location

FRANKFURT am MAIN, DE

Examiner

ROBERTSON, DEIRDRE

Law office

M20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MERZ PHARMA GmbH & CO. KGaA

Representatives

G. Patrick SAGE HUESCHEN AND SAGE PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cerebral and neurologic disorders, diseases and conditions

Publications

History of USPTO decisions and trademark events.

32 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/16/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/16/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/16/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/16/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/18/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/08/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/21/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/21/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/21/2019

E815

TEAS SECTION 8 & 15 RECEIVED

09/09/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

10/08/2013

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

09/06/2013

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

09/05/2013

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/03/2013

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/29/2013

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/28/2013

IUAF

USE AMENDMENT FILED

07/26/2013

EISU

TEAS STATEMENT OF USE RECEIVED

07/26/2013

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/16/2013

PUBO

PUBLISHED FOR OPPOSITION

05/21/2013

NPUB

NOTICE OF PUBLICATION

05/01/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/12/2013

ALIE

ASSIGNED TO LIE

04/12/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/22/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/21/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/20/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/20/2013

CNRT

NON-FINAL ACTION MAILED

09/21/2012

CNRT

NON-FINAL ACTION WRITTEN

09/21/2012

DOCK

ASSIGNED TO EXAMINER

09/20/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/13/2012

NWAP

NEW APPLICATION ENTERED

06/07/2012

Continuous trademark protection

Get notified about every new filing that threatens NAMENDA XR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.